检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Pharmacodynamics and Biomarker Correlates of Imvotamab (IGM-2323), the First-in-Class CD20xCD3 Bispecific IgM Antibody with Dual Mechanisms of Action, in Patients with Advanced B Cell Malignancies

Genevive H. Hernandez, John So,Kathryn A. Logronio,Maya F. Kotturi,Won Seog Kim,Philippe Armand,Chan Y. Cheah,Ajay K. Gopal,Ian W. Flinn,Gareth P. Gregory,Matthew J. Matasar,Loretta J. Nastoupil,Catherine S. Diefenbach,Sung-Soo Yoon,Matthew Ku, Ibrahim Qazi,Maya K. Leabman,Iris Sison,Bruce A. Keyt, Chris H. Takimoto

Blood（2022）

引用 2|浏览11
暂无评分
关键词
imvotamab,malignancies,first-in-class
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要